latest update:
[TrialBase DB]

trial summary · NCT07501078

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

Trial record from the TrialBase DB dataset, status RECRUITING, condition Ulcerative Colitis, sponsored by Muhammad N Aslam, MD. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07501078phase PHASE2enrollment 52start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Ulcerative colitis (UC) is a disease that causes long-term inflammation in the digestive tract, and many people with this condition require surgery to remove the colon and create a new J-pouch for stool. Some patients develop a problem called pouchitis, where this pouch becomes inflamed. Current treatments are limited, and there are no known ways to prevent pouchitis from starting. This study is being done to find out if a natural mineral supplement called Aquamin® can help reduce inflammation and protect the gut lining in people with a J-pouch, and may reduce the risk of pouchitis. By understanding whether Aquamin® is safe and helpful, the study team hopes to find a new and better way to prevent inflammation and improve the long-term health of people with UC.

Source record: https://clinicaltrials.gov/study/NCT07501078

Facts

registry idNCT07501078
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionUlcerative Colitis
sponsorMuhammad N Aslam, MD
sponsor classOTHER
enrollment52
start date2026-11
primary completion2029-08
completion2029-08
results postednot reported

Conditions

  • Ulcerative Colitis
  • Ileal Pouch

Interventions

  • Aquamin
  • Placebo

Countries

  • United States

Intervention types: DRUG

Work with this record